BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36323922)

  • 1. Preventing COVID-19 neurological complications.
    Kiani L
    Nat Rev Neurol; 2022 Dec; 18(12):699. PubMed ID: 36323922
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurological complications of COVID-19.
    Dai X; Cao X; Jiang Q; Wu B; Lou T; Shao Y; Hu Y; Lan Q
    QJM; 2023 Mar; 116(3):161-180. PubMed ID: 36484692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
    Sharifian-Dorche M; Huot P; Osherov M; Wen D; Saveriano A; Giacomini PS; Antel JP; Mowla A
    J Neurol Sci; 2020 Oct; 417():117085. PubMed ID: 32871412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological Complications of COVID-19 in Children.
    Ahmad S
    Pediatr Ann; 2021 Jun; 50(6):e259-e263. PubMed ID: 34115563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological complications of COVID-19.
    Newcombe VFJ; Dangayach NS; Sonneville R
    Intensive Care Med; 2021 Sep; 47(9):1021-1023. PubMed ID: 34097083
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercoagulability of COVID-19 and Neurological Complications: A Review.
    Moore P; Esmail F; Qin S; Nand S; Berg S
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106163. PubMed ID: 34763262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update 2021: COVID-19 from the perspective of neurology].
    Simon OJ; Menzler K; Timmermann L
    Dtsch Med Wochenschr; 2021 Jul; 146(13-14):918-923. PubMed ID: 34256409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 vaccine-related neurological complications need large collaborative studies, not single case reports or small descriptive series.
    Leys D; Edwards M; Vonck K; Taba P; Moro E; Chan A; Sommer C
    Eur J Neurol; 2021 Oct; 28(10):3223. PubMed ID: 33966314
    [No Abstract]   [Full Text] [Related]  

  • 12. Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19.
    Finsterer J; A Scorza F
    Intern Med; 2022 Aug; 61(15):2399. PubMed ID: 35022351
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe neurological complications in critically ill COVID-19 patients.
    Notz Q; Lotz C; Herrmann J; Vogt M; Schlesinger T; Kredel M; Muellges W; Weismann D; Westermaier T; Meybohm P; Kranke P
    J Neurol; 2021 May; 268(5):1576-1579. PubMed ID: 32797297
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurological disease in pregnant females with COVID-19 may not only be attributable to SARS-CoV-2.
    Finsterer J
    Acta Neurol Scand; 2022 Aug; 146(2):199-200. PubMed ID: 35561124
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply: Neurological disease in pregnant females with COVID-19 may not only be attributable to SARS-CoV-2.
    Magalhães JE; Sampaio-Rocha-Filho PA
    Acta Neurol Scand; 2022 Aug; 146(2):201-202. PubMed ID: 35712940
    [No Abstract]   [Full Text] [Related]  

  • 16. Authors Response: Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19.
    Ishiyama H; Ishii J; Yoshimura H; Ohara N; Kohara N; Kawamoto M
    Intern Med; 2022 Aug; 61(15):2401. PubMed ID: 35022358
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological complications in COVID-19 - a new diagnostic challenge.
    Vacaras V; Frunze S; Cordos MA
    J Med Life; 2022 Feb; 15(2):305-306. PubMed ID: 35419093
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-COVID 19 neurological syndrome: Are we facing a neuropsychiatric phenotype?
    Rubiano-Buitrago JD; Rahiran-Ramírez AF; Peña-Vargas DM; Paez-Rincon LA; Lozada-Martinez ID
    J Clin Neurosci; 2022 Mar; 97():106-107. PubMed ID: 35077946
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
    Johansson A; Mohamed MS; Moulin TC; Schiöth HB
    J Neuroimmunol; 2021 Sep; 358():577658. PubMed ID: 34304141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.